These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2581431)

  • 1. Presence of acid-labile interferon in the serum of sarcoidosis patients.
    Rottoli L; Rottoli P; Muscettola M; Grasso G; Bocci V
    Acta Virol; 1985 Jan; 29(1):91. PubMed ID: 2581431
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigation of interferon system in sarcoidosis].
    Ohno S; Kotake S; Matsuda H; Fujii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1983; 87(11):1050-6. PubMed ID: 6199959
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between circulating immune complexes, serum interferon and clinical features in sarcoidosis.
    Biglino A; Albera C; Cariti G; Gioannini P
    Respiration; 1985; 47(4):293-8. PubMed ID: 2409574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
    Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM cold-reactive lymphocytotoxin from sera in patients with sarcoidosis.
    Ikeda S; Ando M; Araki S
    J Clin Lab Immunol; 1984 Oct; 15(2):69-75. PubMed ID: 6335180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the serum of patients with an active form of pulmonary sarcoidosis on the biological activity of lymphocytes and leukocytes of healthy persons].
    Wolska-Goszka L
    Pol Tyg Lek; 1984 Feb; 39(7):209-13. PubMed ID: 6379620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lymphocytotoxicity of serum and its development during ganglio-pulmonary sarcoidosis].
    Brun J; Biot N; Carraz M; Veysseyre C; Prevot J; Perrin-Fayolle M; Traeger J
    Lyon Med; 1969 Jan; 221(4):141-57. PubMed ID: 5779297
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of serum on lymphocyte transformation by phytohemagglutinin in patients with intrathoracic sarcoidosis.
    Terasawa M
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):69-85. PubMed ID: 6205448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibody-dependent cell-mediated cytotoxicity (ADCC) in patients with sarcoidosis (author's transl)].
    Ina Y; Yamamoto M; Takada K; Sugiura T; Suzuki T; Morishita M; Aoki H; Torii Y; Ichimura K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Oct; 18(10):734-8. PubMed ID: 6264192
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis.
    Schmekel B; Håkansson L; Hällgren R; Stålenheim G; Venge P
    Eur J Respir Dis; 1984 Nov; 65(8):592-9. PubMed ID: 6519214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of peripheral blood monocytes in pulmonary sarcoidosis.
    Rømer FK; Christiansen SE; Kragballe K; Herlin T; Madsen M
    Clin Exp Immunol; 1984 Nov; 58(2):357-63. PubMed ID: 6094058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of serum from tuberculous patients on lymphocyte blastic transformation in sarcoidosis].
    Girard JP; Poupon MF; Press P; Favez G
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1986-8. PubMed ID: 5507845
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating immune complexes in sarcoidosis.
    Selroos O; Klockars M; Kekomäki R; Pentinen K; Lindström P; Wager O
    J Clin Lab Immunol; 1980 Mar; 3(2):129-32. PubMed ID: 6259356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum soluble adhesion molecules in patients with sarcoidosis].
    Mukae H; Ashitani J; Ihiboshi H; Taniguchi H; Matsukura S; Iida K; Kadota J; Kohno S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1186-90. PubMed ID: 9493444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ribonucleic acid (RNA) metabolism of monocytes in vitro in normal subjects and in patients with sarcoidosis].
    Schmidt M; Havemann K; Kessler GF; Malchow H
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Feb; 139(2):195-208. PubMed ID: 4245266
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis.
    Yokoyama T; Kanda T; Kobayashi I; Suzuki T
    J Med; 1995; 26(5-6):209-19. PubMed ID: 8721898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant status associated with inflammation in sarcoidosis: a potential role for antioxidants.
    Boots AW; Drent M; Swennen EL; Moonen HJ; Bast A; Haenen GR
    Respir Med; 2009 Mar; 103(3):364-72. PubMed ID: 19010653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired production of interleukin-2 in peripheral blood of patients with sarcoidosis.
    Agostini C; Semenzato G; Zambello R; Trentin L; Luca M; Cipriani A; Tommasini A; Benettollo C; Gasparotto G
    Boll Ist Sieroter Milan; 1985; 64(3):226-31. PubMed ID: 3876104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of biochemical markers in serum for determination of disease activity in sarcoidosis.
    Selroos OB
    Sarcoidosis; 1984 Sep; 1(1):45-9. PubMed ID: 6100924
    [No Abstract]   [Full Text] [Related]  

  • 20. Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis.
    Lambré CR; Pilatte Y; Le Maho S; Greffard A; De Crémoux H; Bignon J
    Clin Exp Immunol; 1988 Aug; 73(2):230-5. PubMed ID: 3180512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.